WASHINGTON (AP) -- Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed birth control pills such as Yaz, in light of growing evidence suggesting the newer contraceptive drugs may be riskier than older drugs....
health regulatorsFDA favors more risk info on birth control pillsHeadlines from the Associated Press Tue, 12/06/2011 - 09:32
FDA favors more risk info on birth control pillsSeattle Post-Intelligencer: Health and Fitness Tue, 12/06/2011 - 08:14
Tags:
FDA issues warnings to 4 hand sanitizer companiesHeadlines from the Associated Press Wed, 04/20/2011 - 15:08
WASHINGTON (AP) -- Federal health regulators have issued warnings to four manufacturers of hand sanitizing products for making unsupported claims about the bacteria-fighting benefits of their products.... FDA issues warnings to 4 hand sanitizer companiesSeattle Post-Intelligencer: Health and Fitness Wed, 04/20/2011 - 14:37
Share: Checks of Pa. abortion clinics find some problemsHeadlines from the Associated Press Tue, 01/25/2011 - 12:13
HARRISBURG, Pa. (AP) -- Health regulators have ordered 14 of Pennsylvania's 22 abortion clinics to correct problems found when inspections resumed last year after more than 15 years.... Amgen bone drug OK'd for use in cancer patientsHeadlines from the Associated Press Thu, 11/18/2010 - 20:09
WASHINGTON (AP) -- Biotech drugmaker Amgen says federal health regulators approved its bone-strengthening drug for preventing fractures and skeletal-problems in patients with advanced cancer.... FDA rejects highly-anticipated diet drug Qnexawashingtonpost.com - Health Thu, 10/28/2010 - 21:40
WASHINGTON -- Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade. FDA denies approval for highly touted diet drugHeadlines from the Associated Press Thu, 10/28/2010 - 19:04
WASHINGTON (AP) -- Drugmaker Vivus Inc. says federal health regulators declined to approve its experimental diet pill Qnexa, which some doctors and investors have touted as a potential blockbuster weight loss medication.... Novartis gains FDA approval for new MS drugHeadlines from the Associated Press Wed, 09/22/2010 - 08:03
WASHINGTON (AP) -- Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.... FDA delays decision on breast cancer drug AvastinHeadlines from the Associated Press Fri, 09/17/2010 - 16:32
WASHINGTON (AP) -- Drugmaker Roche said Friday that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.... |
